UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000007307
Receipt number R000008618
Scientific Title The randomized phaseII study about the skin hazard mitigation in the Erlotinib + oral steroid agent combined therapy and Erlotinib to non-small cell lung cancer patients
Date of disclosure of the study information 2012/02/16
Last modified on 2016/06/21 23:03:30

No. Disposal Last modified on Item of update
1 Insert 2012/02/16 15:31:47
2 Update 2014/03/05 00:02:25 Date of closure to data entry
Date trial data considered complete
3 Update 2016/06/21 23:01:18 TEL
Email
Email
Name of primary person or sponsor
Organization
4 Update 2016/06/21 23:02:03 Date analysis concluded
5 Update 2016/06/21 23:03:30 Recruitment status